Endocrinology

The new safety labeling changes approved by the FDA address the use of SGLT2 inhibitors prior to surgery.

Findings from a retrospective new-user cohort study of female Medicare beneficiaries aged 65 years or older shed light on whether insulin glargine use is associated with increased breast cancer risk...

The US Preventive Services Task Force has released a new draft recommendation on screening for prediabetes and type 2 diabetes in adults.

The new treatment is the first FDA-approved drug to address the overproduction of cortisol in Cushing disease by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis.

Researchers aimed to determine whether target treatment to prevent new-onset atrial fibrillation was effective among patients with primary aldosteronism compared with controls with essential hypertension. ...

The new update accounts for a drug recently approved by the FDA and serves as a “formal amendment” to the 2019 guideline.

The US Food and Drug Administration has released laboratory results of metformin products tested for N-Nitrosodimethylamine.

Following an evidence review led by UK researchers, the National Institute for Health and Care Excellence has issued new guidelines for the assessment and management of thyroid disease.

In a recent study, researchers tested the efficacy of hemoglobin A1c testing in black barbershops in identifying undiagnosed diabetes and prediabetes among black men in Brooklyn, New York.

The US Food and Drug Administration has granted approval to a treatment for thyroid eye disease. It is the first-ever drug to be approved for this indication.